Near the end of the classic 1942 movie Casablanca when Major Strasser is shot, Captain Renault famously pretends not to know ...

Armstrong, PhD, an assistant professor in the Herbold Computational Biology Program in Fred Hutch’s Public Health Sciences ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...

Five years ago, Milton Rubin created the Milton B. Rubin Family Endowed Chair as a means of expressing his gratitude for the ...

It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

Acute myeloid leukemia (AML) is a cancer of the bone marrow and blood. It is also called acute myelogenous leukemia or acute myelocytic leukemia. It happens when some of your blood stem cells stop ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

Faculty profile for Dr. Thomas J. Lynch Jr., president and director, Fred Hutch. Dr. Lynch is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute ...

The International Histocompatibility Working Group provides a comprehensive inventory of HLA reference genes to support worldwide research in immunogenetics.

The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch and ...